Evidence map›Paper›PMID 34664087›Full record

ReviewSeminars in immunopathology2021

The microbiome and IgA nephropathy.

Kei Haniuda, Jennifer L Gommerman, Heather N Reich

Abstract readReview
PubMed Publisher
In one paragraph

Review in Seminars in immunopathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Immune abnormalities in IgA nephropathy.Clinical kidney journal · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. IgA nephropathy: a perspective for 2021.Seminars in immunopathology · 2021
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Kei HaniudaDepartment of Immunology, University of Toronto, Toronto, ON, Canada.
Jennifer L GommermanDepartment of Immunology, University of Toronto, Toronto, ON, Canada.
Heather N ReichDivision of Nephrology, Department of Medicine, University of Toronto and University Health Network, Toronto, ON, Canada. Heather.Reich@uhn.ca.ORCID 0000-0001-8951-5518
University of Toronto · CAUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immunopathogenic mechanisms underlying immunoglobulin A nephropathy (IgAN) are poorly understood, yet it is one of the most common causes of kidney failure globally. The commonly referenced syndrome of synpharyngitic gross hematuria as a presenting feature of IgAN has led to a logical association between infections and development of IgAN, however no pathogenic organism has been clearly linked to IgAN. Advances in sequencing technology have enabled more detailed characterization of host microbial communities, and highlighted the interrelationship between microbiota and immune responses in health and disease. This review will summarize current thinking on the relationship between microbiota and development of IgAN with a focus on recent studies relating aberrant mucosal IgA-biased immune responses to microbiota and how this may be related to the immunopathogenesis of IgAN.

Indexed as

Gastrointestinal MicrobiomeGlomerulonephritis, IGAMicrobiotaHumansImmunity, MucosalImmunoglobulin AImmunoglobulin AAPRILBAFFB cellGlomerulonephritisIgA nephropathyMicrobiomePlasma cell

Identifiers

PMID34664087
OpenAlexW3207335216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.